Early Stage Pd Dopaminergic Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
This page provides comprehensive information about the cell type. See the content below for detailed information.
Early-stage Parkinson's disease dopaminergic neurons refer to the vulnerable SNpc neurons in the initial phases of PD, before significant cell death occurs. These neurons exhibit subtle molecular and physiological changes that may be reversible and represent therapeutic targets.
- Alpha-synuclein - Early aggregation
- Mitochondrial dysfunction - Complex I deficiency
- Oxidative stress - ROS accumulation
- Calcium dysregulation - L-type channel hyperactivity
- Lipid alterations - Membrane composition changes
- Dendritic beading
- Synaptic retraction
- Axonal dystrophy
- Neuromelanin redistribution
- Pacemaker activity - Autonomous firing increases calcium
- High energy demand - Extensive axonal arborization
- Neuromelanin - Iron accumulation
- Long axons - Transport challenges
- Neuroinflammation
- Microglial activation
- Astrocyte reactivity
- Vascular compromise
| Marker |
Change |
Detection |
| α-Syn oligomers |
Increased |
CSF, blood |
| DJ-1 |
Decreased |
CSF |
| UCH-L1 |
Increased |
CSF |
| NfL |
Mildly elevated |
Blood |
- DaTscan (dopamine transporter)
- FDG-PET (metabolic changes)
- Neuromelanin MRI
- Transcranial ultrasound (SN echogenicity)
- Calcium channel blockers - Isradipine
- MAO-B inhibitors - Rasagiline, selegiline
- CoQ10 - Mitochondrial support
- GLP-1 agonists - Exenatide (trial results)
- Alpha-synuclein immunotherapy
- Gene therapy (AAV-GAD, AADC)
- Cell replacement (stem cells)
The study of Early Stage Pd Dopaminergic Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Surmeier DJ, et al. (2017). Calcium and Parkinson's disease. Nature Reviews Neuroscience.
- Kalia LV, Lang AE (2015). Parkinson's disease. Lancet.
- Poewe W, et al. (2017). Parkinson's disease. Nature Reviews Disease Primers.